Isolation Policy
Version
5
Name of responsible (ratifying) committee
Infection Prevention Management Committee
Date ratified
14 May 2015
Document Manager (job title)
Dr Caroline Mitchell (Head of Infection Prevention)
Date issued
17 July 2015
Review date
16 July 2017
Electronic location
Infection Prevention and Control Policies
Related Procedural Documents
Key Words (to aid with searching)
Hand Hygiene policy
MRSA/MSSA policy
Standard Infection Control Precautions policy
Clostridium difficile infection (CDI) management policy
Management of Outbreaks of Viral Diarrhoea &
Vomiting policy
Decontamination policy
Viral Haemorrhagic Fever Policy
Isolation, transmission precautions, source isolation,
protective isolation
Version Tracking
Version
Date Ratified
5
14/05/15
Brief Summary of Changes
Author
Update of Notification of Infectious Diseases, contact
details for PHE Wessex Centre, addition of quick
reference guide
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Caroline Mitchell
Page 1 of 14
CONTENTS
QUICK REFERENCE GUIDE ............................................................................................................. 3
1. INTRODUCTION.......................................................................................................................... 4
2. PURPOSE ................................................................................................................................... 4
3. SCOPE ........................................................................................................................................ 4
4. DEFINITIONS .............................................................................................................................. 4
5. DUTIES AND RESPONSIBILITIES .............................................................................................. 4
6. PROCESS ................................................................................................................................... 5
7. TRAINING REQUIREMENTS .................................................................................................... 10
8. REFERENCES AND ASSOCIATED DOCUMENTATION .......................................................... 10
9. EQUALITY IMPACT STATEMENT ............................................................................................ 10
10. MONITORING COMPLIANCE WITH PROCEDURAL DOCUMENTS ........................................ 12
APPENDIX 1: Standard Isolation Signage (available from Infection Prevention Team) ..................... 13
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 2 of 14
QUICK REFERENCE GUIDE
For quick reference the guide below is a summary of actions required. This does not negate the need
for the document author and others involved in the process to be aware of and follow the detail of this
policy.
Confirmed or suspected
Infectious Disease (see 6.14
Alert Organisms)
NO
No further action required
YES
Refer to Infection Prevention or
Medical Microbiology
immediately
YES
Isolate and start transmission
precautions (review need for
isolation daily)
YES
Transfer patient into isolation
and start transmission
precautions (review need for
isolation daily)
YES
Transfer patient into isolation
and start transmission
precautions. Inform medical
team of transfer (review need for
isolation daily)
YES
Suspected or confirmed MDR
Tuberculosis or Viral
Haemorrhagic Fever?
NO
Single room available within
clinical area/ward?
NO
Escalate to Specialty Flow Coordinator
Single room available within
specialty footprint/CSC?
NO
Escalate to Bed Meeting / Duty
Hospital Manager
Single room available within
hospital?
NO
Escalate to Infection Prevention
Team (24 hours per day) for risk
assessment
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Always explain the
needs for isolation
(including risks and
benefits) to the patient
Page 3 of 14
1.
INTRODUCTION
Isolation refers to the use of a single room as a physical barrier to help prevent the transmission of
potentially infectious organisms. Isolation has been shown to be effective in reducing onwards
spread of infection but is only one element of a successful infection prevention strategy. Other
measures, such as environmental and equipment cleaning, the correct use of personal protective
equipment (PPE) and above all hand hygiene are equally or more important.
2. PURPOSE
The aim of this policy is to ensure appropriate use of isolation facilities based on local risk
assessment in accordance with the Health & Social Care Act (DH 2010).
This policy should be used with reference to the:
 Hand Hygiene policy
 MRSA/MSSA policy
 Standard Infection Control Precautions policy
 Clostridium difficile infection (CDI) management policy
 Management of Outbreaks of Viral Diarrhoea & Vomiting policy
 Decontamination policy
3. SCOPE
This policy applies to all PHT Healthcare workers (HCW), including agency, bank and locum staff,
Carillion staff including porters and house keepers and visiting HCW’s from other organisations.
‘In the event of an infection outbreak, flu pandemic or major incident, the Trust recognises that it
may not be possible to adhere to all aspects of this document. In such circumstances, staff
should take advice from their manager and all possible action must be taken to maintain ongoing
patient and staff safety’
4. DEFINITIONS
Nil
5. DUTIES AND RESPONSIBILITIES
Infection Prevention Team:
 Review and update Isolation policy
 Give additional advice regarding the management of patients requiring isolation where
required
 Include isolation precautions in all induction and update training for clinical staff
 Promote good practice and challenge poor practice
 Conduct audit and inspection of isolation practice with feedback to clinical staff
Microbiologists:
 Alert Infection Prevention Team and clinical teams of patients requiring isolation following
confirmation of certain infections
 Advise clinical staff of the need for isolation at the time of notification of an infectious (or
potentially infectious) disease
Patient Flow / Duty Hospital Managers:
 Facilitate placement of patients with potential or known infections into appropriate isolation
rooms as soon as possible
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 4 of 14



Monitor the appropriate usage of isolation rooms
Escalate difficulties in isolation to the Infection Prevention Team
Report breaches of isolation to Infection Prevention Team and by incident reporting
Matrons / Senior and Ward Sisters:
 Must establish a cleanliness culture across their units and promote compliance with infection
prevention guidelines
 Promote good practice and challenge poor practice
Medical Staff:
 Ensure compliance with infection prevention policies
 Follow advice from the Infection Prevention Team relating to isolation of patients
 Review the need for isolation on a daily basis
All Healthcare Staff:
 Must be familiar with and adhere to the relevant infection prevention policies to reduce the risk
of cross infection of patients
 Must adhere to the full terms and conditions of isolation documented in this policy
 Must use the risk assessment process to identify the isolation priorities of individual patients
 Promote good practice and challenge poor practice
 Refer to the infection prevention team if unable to follow the policy guidelines
 Keep their patient informed of their infection status and provide information as necessary
 Must ensure that patients who are isolated have access to investigations and rehabilitation
6. PROCESS
6.1 Principles of Isolation:
 Isolation is one aspect of effective infection prevention policy and standard infection control
precautions should be applied to all patients without exception
 Isolation must never compromise the safety or clinical care of a patient
 The benefits of isolation should be weighed against the potential risks to the patient (patient’s
mental state, severity of illness etc) and to other (public health risk) and patients should
receive preparatory and ongoing information relating to their condition, treatment and
rationale behind isolation
 Infection risk should be constantly assessed as part of the ongoing clinical patient
assessment and managed accordingly.
 Isolation must be discontinued as soon as the risk of onwards transmission of infection has
diminished or resolved
6.2 Source Isolation:
Refers to the physical isolation of a patient with suspected or confirmed transmissible infection in a
single room in order to prevent or reduce the risk of onwards transmission by blocking the route of
spread.
Source isolation of infectious patients should occur in:
 A neutral pressure single room with ante room OR
 A negative pressure single room with ante room OR
 A standard single room
 The room should be cleaned after all other ward cleaning has been carried out
6.3 Protective Isolation:
Refers to the physical isolation of a susceptible patient in a single room in order to reduce the risk of
exposure to potentially harmful micro-organisms.
Protective isolation of immunocompromised/susceptible patients should occur in:
 A positive pressure single room with ante room OR
 A neutral pressure single room
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 5 of 14

The room should be cleaned before any ward cleaning is carried out
6.4 Cohorting:
An alternative of last resort to single room isolation is the cohorting of patients together with the
same condition. However, not all patients with similar symptoms e.g. diarrhoea, have the same
aetiology and many patients with the same organism e.g. C.difficile will have different strains.
Cohorting should only be undertaken following discussion with and approval by the infection
prevention team.
6.5 Escalation Strategy:
 Potentially infectious patients should be isolated within 2 hours of first suspicion
 Where no suitable single room is available in the immediate clinical area, staff should escalate
to:
i. Specialty flow coordinator and if no flow coordinator to Matron (then)
ii. Duty hospital manager (then)
iii. (On-call) Infection Prevention Team
6.6 Isolation Preference:
i. Isolation room in the immediate clinical area/ward
ii. Isolation room within the same Clinical Service Centre
iii.
Isolation room outside the Clinical Service Centre
It is appropriate in most circumstances to transfer the patient outside the specialty of Clinical
Service Centre to achieve isolation, provided the responsible medical team is aware.
6.7 Asset List:
The Trust currently has:
 10 positive pressure single rooms with ante room (protective isolation) F6 ward
 6 neutral pressure single rooms with ante room (source or protective) E5 ICU
 12 neutral pressure single rooms with ante room (source or protective) G5 ward (emergency
use only)
 2 adjustable positive/neutral pressure single rooms with ante room F5 ward
 >220 standard single rooms across all wards
6.7 Common Principles of Isolation:
 The need for isolation should be clearly communicated to the patient, family members (if
appropriate) and clinical staff
 The need for isolation should be reviewed on a daily basis. Discuss specific cases with the
Infection Prevention Team
 A generic isolation sign should be prominently displayed on the room door to alert people to
potential risk without compromising confidentiality (appendix 1 & 2)
 Ensure that the door remains closed, especially when airborne infections are
suspected/confirmed e.g. pulmonary TB, influenza
6.8 Hand Hygiene & PPE: (see hand hygiene and Standard Infection Control Precautions Policies)
 Hand hygiene facilities should be easily accessible inside and outside of the single room
 Clinical staff and visitors must decontaminate hands on entry and exit of the room
 Patients should be strongly encouraged to clean hands regularly, either with soap and water,
or cleansing wipes, particularly after using the toilet and before eating
 PPE (gloves, aprons/gowns, face masks/visors (where appropriate)) should be prominently
available outside the room entrance
 Protective equipment should only be worn by relatives carrying out direct ‘hands on care’ and
not for routine social visiting
 Limit and restrict the number of staff and visitors who come into contact with the patient to
reduce the potential to spread or introduce infection. Where immunity to a condition occurs
e.g. Chicken Pox, staff and visitors should be restricted to those who are non-susceptible
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 6 of 14
6.9 Cleaning, Linen & Waste:
 The room must be cleaned at least once daily with dedicated cleaning equipment using a
suitable agent (hypochlorite e.g. Actichlor plus or chlorine dioxide e.g. Difficil-S) focusing on
common touch points (door handles, bed rails, tables, chair arms, taps etc)
 Carillion are responsible for cleaning the clinical environment, clinical staff are responsible for
cleaning clinical equipment
 Ensure that the room is kept clean and uncluttered, with flat surfaces clear of unnecessary
items
 Only stock that is required should be taken into the room
 Clinical equipment inside the room must be dedicated to the patients until the patient is
discharged or no longer deemed to be infectious. The equipment must then be appropriately
decontaminated before being used on other patients. If equipment cannot be restricted to a
single patient then equipment must receive a thorough clean with a chlorine agent before
leaving the room
 Charts and notes should be kept outside the room to reduce the risk of contamination
 Clinical waste bin with either a yellow/black ‘tigerstripe’ bag (non-infectious offensive waste for
protective isolation) or orange (infectious offensive waste for source isolation) should be kept
in the room as appropriate
 All linen should be bagged at the bedside as infectious linen in appropriate coloured bags
6.10 Transport of Infectious Patients:
 Movement of infectious or potentially infectious patients should be kept to a minimum. When it
is necessary to transfer patients to other wards or departments, precautions to minimise the
risk of transmission, based on the route of spread, must continue
 If it is possible to delay an investigation without adversely affecting the patients management
this should be considered. However, infectious disease should not compromise urgent clinical
investigations
 The receiving area must be informed prior to transfer to ensure appropriate precautions are in
place and that suitable segregation facilities are available
 Patients with known or suspected infections should not be placed in waiting areas and
adequate time for post procedure cleaning should be built into clinic/theatre schedules
6.11 Terminal Room Cleaning:
All rooms must be thoroughly cleaned with hypochlorite e.g. Actichlor plus or chlorine dioxide e.g.
Difficil-S when vacated. This includes between patients with the same organism.
 Curtains must be removed and sent to the laundry as infected linen
 All disposable equipment should be discarded into orange clinical waste bags
 All clinical equipment, including bed frames should be thoroughly cleaned by clinical staff
 All areas of the room should be cleaned using dispoable clothes with particular attention paid
to touch points and horizontal surfaces e.g. door handles, taps, dispensers, nurse call system,
toilet areas, bed frame, tables, lockers, chairs
 For certain infections (e.g. C.difficile, Carbapenem resistant Organisms, Gylcopeptide
resistant Enterococi, Acinetobacter, other multi-drug resistant organisms), decontamination
with Hydrogen Peroxide Vapour may be required – contact the Infection prevention Team to
arrange.
6.12 Very High Risk Patients:
Adults and children with suspected or known infectious Multi Drug Resistant (MDR TB) and
Extensively Drug Resistant TB (XDR-TB) must be admitted to a negative pressure room. These
patients should be referred to University Hospital Southampton Isolation Unit via Medical
Microbiology.
Clinicians caring for a patient with recent foreign travel with suspected Viral Haemorrhagic Fevers
(VHF) must immediately contact the Microbiologist on call for advice on where to refer the patient.
The patient must be isolated (preferably in a negative pressure single room – currently designated
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 7 of 14
G5 ward) as soon as possible.
For confirmed VHF, the patient should be transferred to the Royal Free Hospital London which
has appropriate facilities for the management of these patients.
Arrangements should be made in conjunction with the Public Health England (Wessex Centre).
Public Health England (Wessex Centre)
Unit 8, Fulcrum 2,
Solent Way, Whiteley
Fareham, Hampshire
PO15 7FN
Tel: 0345 055 2022
6.13 Notification of Infectious Diseases:
It is the responsibility of the attending registered medical practitioner to notify infectious diseases.
Notification forms can be obtained via the GOV.UK website at
https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids
Diseases notifiable (to Local Authority Proper Officers) under the Health Protection (Notification)
Regulations 2010:
































Acute encephalitis
Acute infectious hepatitis
Acute meningitis
Acute poliomyelitis
Anthrax
Botulism
Brucellosis
Cholera
Diphtheria
Enteric fever (typhoid or paratyphoid fever)
Food poisoning
Haemolytic uraemic syndrome (HUS)
Infectious bloody diarrhoea
Invasive group A streptococcal disease
Legionnaires’ Disease
Leprosy
Malaria
Measles
Meningococcal septicaemia
Mumps
Plague
Rabies
Rubella
SARS
Scarlet fever
Smallpox
Tetanus
Tuberculosis
Typhus
Viral haemorrhagic fever (VHF)
Whooping cough
Yellow fever
Other diseases that may present significant risk to human health should be reported under the
category ‘other significant disease’.
As of April 2010, it is no longer a requirement to notify the following diseases: Dysentery,
Leptospirosis, Ophthalmia neonatorum, Relapsing fever and Viral hepatitis.
6.14 Alert Organisms:
The following list is provided as guidance and is not exhaustive. For complicated presentations,
please contact the Infection Prevention Team.
Alert Organism
Abscesses e.g.
quinsy
Blood borne virus e.g.
HIV, Hepatitis B,C
Risk Factors
Assess the patient
Campylobacter
Immunocompromise
Carbapenem
Resistant Organisms
Chicken Pox
Hospital (particularly ICU)
admission in at risk areas
Rash developed within
Assess the patient
Isolation Requirement
Isolate until 24-48 hours of appropriate antibiotics. Discuss
with the Infection Prevention Team
Isolation not required unless there is a high risk of blood or
blood stained body fluid splash. Additional precautions may
be required within the renal dialysis unit
Isolate whilst acutely symptomatic (80-90% of cases
resolve by day 7) but excretion in stools may continue for
2-7 weeks
Isolate and full precautions for the duration of hospital
admission (and any readmission)
Immediate isolation required. Only staff with a history of
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 8 of 14
the previous 10 days or
vesicles not crusted over
Clostridium difficile
Toxin positive
Carriage (GDH or PCR
positive, Toxin negative)
CJD
Cryptosporidium
immunocompromise
Diarrhoea (infectious)
Exclude overflow,
laxatives, ng feeds,
crohns/colitis etc
Extended Spectrum
Beta-Lactamase
(ESBL) producing
organisms in urine
Incontinent patient
Catheterised or fully
continent patient
ESBL producing
organisms in other
sites
GRE Glycopeptide
resistant enterococci
(including VRE)
Assess individual risks
e.g. weeping wounds etc.
Influenza (including
Avian flu and H1N1)
Legionella
(legionnaires disease)
Malaria
Confirmed
Suspected
Measles
Suspected
meningitismeningococcal
Meticilin Resistant
Staphylococcus
aureus
(MRSA)
Mumps
Norovirus
Salmonella (inc. typhi
(typhoid fever))
Sputum Positive with
productive cough, flaking
skin condition, wet
wounds with break
through
Skin colonisation only
Chicken pox (or serologically confirmed immunity) should
have contact with this patient. Patient can be removed from
isolation once vesicles fully crusted
Isolate for duration of hospital admission, regardless of
symptoms. Isolate if readmitted within 6 months of original
diagnosis
Isolate for duration of hospital admission, regardless of
symptoms. Isolate if readmitted within 6 months of original
diagnosis
Isolation not required. See CJD policy for advice re surgical
procedures. Inform microbiologist on call immediately if
diagnosis is suspected to ensure safe handling of
specimens
Isolate whilst symptomatic (2 days to 4 weeks),
immunocompromised patients will take longer to clear
infection
Immediate isolation, preferably within 2 hours of onset of
symptoms until full resolution of diarrhoea and formed stool
(with the exception of C.difficile patients who remain
isolation for the duration of admission)
Isolation required. Encourage good hand and personal
hygiene. Dedicated commode (or lavatory) cleaned
between each use
Isolation preferable. Encourage good hand and personal
hygiene. Dedicated commode (or lavatory) cleaned
between each use
Isolation required. Encourage good hand hygiene and
personal hygiene. If possible use a dedicated toilet.
Discuss with Infection Prevention Team if required
Isolate for duration of hospital admission, regardless of
symptoms. Isolate if readmitted. Patient will have longterm skin and intestinal carriage. Dedicated bathroom
facilities. Encourage good hand hygiene and personal
hygiene
Isolate until patient has completed course of antivirals and
is symptom free. FFP3 face masks to be worn for aerosol
generating procedures. FFP1 face masks to be worn during
non aerosol generating close contact.
For avian influenza inform microbiologist on call
immediately if diagnosis is suspected
Not transmitted between individuals, no isolation required
Not transmitted between individuals, no isolation required
Febrile illness with a history of travel to tropical/subtropical
area should be managed as high risk until malaria
diagnosis confirmed
Isolate until 5 days after onset of rash
Isolate until 24 hours of antibiotics. FFP1 face mask to be
worn during any procedure likely to generate respiratory
droplets. Inform occupational health if in direct contact with
respiratory secretions e.g. during resuscitation
Immediate isolation required.
Discuss with the Infection Prevention Team
If no single room available, may be treated in a main bay if
located next to a hand washing sink with full transmission
precautions
Isolate until 9 days after onset of rash
Isolate immediately on first episode of projectile vomiting or
diarrhoea, until 48 hours after complete cessation of
symptoms
Isolate infants until clinical recovery occurs. Cohort nursing
may be considered in certain circumstances if all patients
RSV status known
Isolate immediately (excretion may continue for 2 days to 2
months, median 5 days)
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 9 of 14
Shigella
Shingles
Tuberculosis
Rash in an exposed area
with wet lesions
Rash in a covered area
with wet/drying lesions
Confirmed pulmonary TB
with a productive
cough
Suspected pulmonary TB
AFB negative pulmonary
TB/ TB closed site
Suspected/ Confirmed
drug resistant TB
Norwegian Scabies
Often affects immunocompromised patients
Classical scabies
Group A
Streptococcus
SARS
Awaiting diagnosis
Vancomycin resistant
enterococci (VRE)
Viral Hemorrhagic
Fever
See GRE
Isolate whilst acutely symptomatic (excretion may continue
for 2-4 weeks post acute illness)
Isolate until lesions are fully dried. Only staff with a history
of Chicken pox (or serologically confirmed immunity)
should have contact with this patient
May be treated in a main bay provided no
immunocompromised patients are in the room
Isolate until 14 days continuous, compliant treatment. Use
FFP 2 or 3 facemask for contact
Isolate until 3 negative sputum specimens on microscopy
No requirement to isolate
Discuss with TB nurse specialist and Infection Prevention
Team. Will require isolation in a negative pressure side
room and transfer to alternative site
Highly transmissible, isolate until full course of treatment
has been completed (minimum 2 treatments)
Discuss with Infection Prevention Team
Isolate until 48 hours of appropriate antibiotics
Immediate isolation required. Inform Infection Prevention or
Microbiologist on call immediately if diagnosis is suspected
Discuss with Infection Prevention Team or Microbiologist
on call immediately if diagnosis is suspected. Will require
isolation in a negative pressure side room and transfer to
alternative site
7. TRAINING REQUIREMENTS



Clinical and non-clinical staff to receive practical hand hygiene training on induction and every
2 years thereafter (Infection Prevention Team)
Clinical and non-clinical staff to receive face-to-face induction training on aspects of infection
prevention & isolation (Infection Prevention Team)
Update training to be delivered as part of Patient Safety & Quality Days, departmental and
drop in days, Link Advisor days and Senior Doctors Training (Infection Prevention Team)
8. REFERENCES AND ASSOCIATED DOCUMENTATION
Ayliffe, G.A.J, Babb, J.R, Taylor, L.Z (2001) Hospital Acquired Infection, Principles and Prevention.
Third Edition, Arnold Page
Department of Health (2010) The Health Act 2008 Code of Practice for the Prevention and Control
of Health Care Associated Infections London DH, 2010
Kundrapu S, Sunkesula V, Jury LA, Sitzlar BM, Donskey CJ. Daily disinfection of high-touch
surfaces in isolation rooms to reduce contamination of healthcare workers’ hands. Infect Control
Hosp Epidemiol 2012;33:1039–1042.
9. EQUALITY IMPACT STATEMENT
Portsmouth Hospitals NHS Trust is committed to ensuring that, as far as is reasonably practicable,
the way we provide services to the public and the way we treat our staff reflects their individual
needs and does not discriminate against individuals or groups on any grounds.
This policy has been assessed accordingly
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 10 of 14
Our values are the core of what Portsmouth Hospitals NHS Trust is and what we cherish. They are
beliefs that manifest in the behaviours our employees display in the workplace.
Our Values were developed after listening to our staff. They bring the Trust closer to its vision to be
the best hospital, providing the best care by the best people and ensure that our patients are at the
centre of all we do.
We are committed to promoting a culture founded on these values which form the ‘heart’ of our
Trust:
Respect and dignity
Quality of care
Working together
No waste
This policy should be read and implemented with the Trust Values in mind at all times.
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 11 of 14
10. MONITORING COMPLIANCE WITH PROCEDURAL DOCUMENTS
This document will be monitored to ensure it is effective and to assurance compliance.
Minimum
requirement to
be monitored
Lead
Tool
Frequency of
Report of
Compliance
Time to isolation
for patients with
suspected
infectious
diarrhoea
IPCT
Infection
Prevention
Dashboard
Weekly for all
areas
Policy audit report to:
Quality of Isolation
(PPE, Clutter,
Signage, Chlorine
Cleaning)
IPCT
Infection
Prevention
Dashboard
Weekly for all
areas
Policy audit report to:
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Reporting
arrangements


Lead(s) for acting
on
Recommendations
HoN
HoN, MM,
Consultants, Ward
Managers, IPMC
HoN, MM,
Consultants, Ward
Managers, IPCM
Page 12 of 14
HoN
APPENDIX 1: Standard Isolation Signage (available from Infection Prevention Team)
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 13 of 14
APPENDIX 2: Standard Isolation Signage (available from Infection Prevention Team)
Isolation Policy
Issue Number: 5
Issue Date: 17 July 2015
Review date: 16 July 2017 (unless requirements change)
Page 14 of 14